Further, the guidelines directly state “GNAS mutation at codon 201 is exclusively observed in IPMN, and assessment of GNAS mutation is useful to discriminate IPMN from MCN”. The gene discussed is GNAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.